Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Circulation|July 1, 1976
Patient acceptance of guanethidine as therapy for mild to moderate hypertension. A comparison with reserpineR K Ferguson, R J Rothenberg, A S NiesClinical Pharmacology and Therapeutics|January 1, 1977
Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertensionR K Ferguson, D M Turek, D R RovnerFederation Proceedings|April 1, 1984
Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapyW B Abrams, R O Davies, R K FergusonAmerican Heart Journal|May 1, 1996
Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitalsB G Phillips, J M Yim, E J Brown, et al.Journal of Clinical Pharmacology|January 1, 1989
The antihypertensive response to lisinopril: the effect of age in a predominantly black populationD M Cummings, P Amadio, E J Taylor, et al.The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteersG J Gormley, E Stoner, R S Rittmaster, et al.Annals of Internal Medicine|August 15, 1993
Influence of digoxin immune Fab therapy and renal dysfunction on the disposition of total and free digoxinM R Ujhelyi, S Robert, D M Cummings, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1984
Hemodynamic and humoral responses to enalapril and nifedipine in the ratM E Vincent, B N Swanson, K Shepley, et al.Clinical Pharmacology and Therapeutics|October 1, 1993
Disposition of digoxin immune Fab in patients with kidney failureM R Ujhelyi, S Robert, D M Cummings, et al.Pharmacotherapy|May 1, 1986
Acute hepatotoxicity after excessively high doses of carbamazepine on two occasionsD R Luke, M L Rocci, D H Schaible, et al.Pageof 14